Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Cross-reactivity

Cross-reactivity

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Search for doubly charged Higgs bosons with lepton-flavor-violating decays involving tau leptons.

Physical review letters·2008

Same author

Gas-phase vibrational spectroscopy and ab initio study of organophosphorus compounds: discrimination between species and conformers.

The journal of physical chemistry. B·2008

Same author

Search for pair production of scalar top quarks decaying to a tau lepton and a b quark in pp over collisions at sqrt s=1.96 TeV.

Physical review letters·2008

Same author

Tumor necrosis factor-alpha -308 polymorphism in infertile men with altered sperm production or motility.

Human reproduction (Oxford, England)·2008

Same author

Search for resonant tt[overline] production in pp[overline] collisions at sqrt[s]=1.96 TeV.

Physical review letters·2008

Same author

Inter-observer agreement in the identification of the two bundles of the anterior cruciate ligament using magnetic resonance imaging.

Surgical and radiologic anatomy : SRA·2008

Same journal

V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.

Vaccine·2026

Same journal

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.

Vaccine·2026

Same journal

Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.

Vaccine·2026

Same journal

Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.

Vaccine·2026

Same journal

Public health benefits of maternal influenza vaccination among pregnant women and infants <6 months in the United States, 2011-2020.

Vaccine·2026

Same journal

Effectiveness and acceptability of an opt-out nudge to promote influenza vaccination among medical residents: A randomized controlled trial.

Vaccine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Bluetongue vaccines.

R Noad¹, P Roy

¹Department of Pathology and Infectious Diseases, Royal Veterinary College, Hawkshead Lane, Hatfield AL9 7TA, United Kingdom.

|October 20, 2009

Summary

This summary is machine-generated.

Bluetongue virus, a significant livestock pathogen, has spread globally. Its 24 serotypes necessitate ongoing vaccine development to combat new outbreaks and protect agriculture.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

Area of Science:

Veterinary Virology
Epidemiology
Immunology

Background:

Bluetongue virus (BTV) is an insect-borne pathogen affecting livestock.
Historically endemic to India and Africa, BTV now has a worldwide distribution, excluding Antarctica.
Recent European outbreaks highlight the economic and agricultural impact of BTV, driving vaccine research.

Purpose of the Study:

To review the global spread and serotypic diversity of Bluetongue virus.
To discuss the implications of BTV variability for vaccine efficacy and disease control.
To emphasize the need for continuous development of safe and effective BTV vaccines.

Main Methods:

Literature review of Bluetongue virus epidemiology and immunology.
Analysis of BTV serotype distribution and vaccine challenges.
Synthesis of current knowledge on BTV protection determinants.

Main Results:

Bluetongue virus is now a global concern, present on all continents except Antarctica.
There are 24 distinct serotypes of Bluetongue virus, complicating vaccine strategies.
Existing vaccination in some regions does not guarantee protection against all BTV serotypes.

Conclusions:

The global spread and genetic diversity of Bluetongue virus pose a significant threat to livestock health and trade.
Effective control requires vaccines that address the wide range of circulating serotypes.
Continued research and surveillance are crucial for managing Bluetongue virus outbreaks.